Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
Hemoglobin switching protocols in thalassemia - Experience with sodium phenylbutyrate and hydroxyurea
George J. Dover
Johns Hopkins Hospital
Research output
:
Contribution to journal
›
Article
›
peer-review
17
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Hemoglobin switching protocols in thalassemia - Experience with sodium phenylbutyrate and hydroxyurea'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
4-phenylbutyric acid
67%
Thalassemia
51%
Hydroxyurea
51%
Hemoglobins
34%
Iron Overload
34%
Chelation Therapy
19%
Globins
18%
Erythropoietin
15%
Bone Marrow Transplantation
14%
Combination Drug Therapy
14%
Serum
6%
Therapeutics
4%
Arts & Humanities
Hemoglobin
52%
Iron
33%
Chelation Therapy
29%
Bone Marrow
18%
Transfusion
18%
Transplantation
16%
Transcription
14%
Drugs
11%
Regular
11%
Therapy
11%
Therapeutics
11%
Cells
10%
Evaluation
7%
Chemical Compounds
Sodium Phenylbutyrate
100%
Hydroxyurea
62%
Hemoglobin
39%
Erythropoietin
20%
Red
9%
Drug
7%